HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shilpa Gupta Selected Research

hentriacontane

8/2017Anti-inflammatory potential of hentriacontane in LPS stimulated RAW 264.7 cells and mice model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shilpa Gupta Research Topics

Disease

61Neoplasms (Cancer)
04/2024 - 04/2007
29Prostatic Neoplasms (Prostate Cancer)
03/2024 - 01/2011
24Carcinoma (Carcinomatosis)
03/2024 - 04/2014
14Urinary Bladder Neoplasms (Bladder Cancer)
12/2023 - 07/2013
11Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 12/2011
10Disease Progression
03/2024 - 10/2013
7COVID-19
10/2023 - 10/2020
6Neoplasm Metastasis (Metastasis)
02/2024 - 01/2019
4Kidney Neoplasms (Kidney Cancer)
04/2024 - 12/2011
4Fatigue
01/2023 - 11/2018
4Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2017
4Inflammation (Inflammations)
11/2021 - 08/2017
3Thromboembolism
10/2023 - 11/2021
3Squamous Cell Carcinoma of Head and Neck
01/2022 - 11/2016
3Edema (Dropsy)
11/2021 - 04/2018
2Body Weight (Weight, Body)
03/2024 - 07/2012
2Bone Resorption
02/2024 - 04/2023
2Exanthema (Rash)
01/2023 - 12/2015
2Cytokine Release Syndrome
01/2023 - 10/2020
2Hematologic Neoplasms (Hematological Malignancy)
03/2022 - 07/2014
2Infections
11/2021 - 04/2007
2Thrombocytopenia (Thrombopenia)
01/2020 - 01/2013
2Febrile Neutropenia
10/2018 - 06/2016
2Adenocarcinoma
01/2018 - 06/2016
2Penile Neoplasms (Penile Cancer)
11/2016 - 08/2014
2Stomach Neoplasms (Stomach Cancer)
06/2016 - 01/2016
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2016 - 01/2014
2Breast Neoplasms (Breast Cancer)
12/2015 - 10/2011
1Transitional Cell Carcinoma
04/2024
1Urologic Neoplasms (Urological Cancer)
01/2023
1Superinfection
03/2022

Drug/Important Bio-Agent (IBA)

17pembrolizumabIBA
03/2024 - 01/2016
15Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2011
14PlatinumIBA
03/2024 - 01/2017
13Cisplatin (Platino)FDA LinkGeneric
03/2024 - 03/2014
12Immune Checkpoint InhibitorsIBA
04/2024 - 07/2019
12AndrogensIBA
03/2024 - 10/2013
10Hormones (Hormone)IBA
03/2024 - 01/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 12/2011
4bicalutamide (Casodex)FDA LinkGeneric
03/2024 - 03/2015
4orteronelIBA
03/2024 - 10/2022
4GemcitabineFDA Link
03/2024 - 03/2014
4enfortumab vedotinIBA
03/2024 - 03/2022
4Proteins (Proteins, Gene)FDA Link
12/2023 - 10/2013
4NivolumabIBA
12/2023 - 01/2018
4avelumabIBA
10/2023 - 01/2018
4atezolizumabIBA
01/2022 - 01/2017
4Androgen Receptors (Androgen Receptor)IBA
07/2020 - 03/2015
3Prostate-Specific Antigen (Semenogelase)IBA
03/2024 - 03/2015
3DNA (Deoxyribonucleic Acid)IBA
11/2023 - 10/2013
3Oxygen (Dioxygen)IBA
08/2023 - 04/2007
3CarrageenanIBA
11/2021 - 04/2018
3Abiraterone AcetateIBA
02/2021 - 10/2018
2Immunoconjugates (Immunoconjugate)IBA
04/2024 - 03/2022
2infigratinibIBA
04/2024 - 07/2022
2Carboplatin (JM8)FDA LinkGeneric
03/2024 - 01/2022
2Alkaline PhosphataseIBA
02/2024 - 04/2023
2pyridinolineIBA
02/2024 - 04/2023
2CollagenIBA
02/2024 - 04/2023
2collagen type I trimeric cross-linked peptideIBA
02/2024 - 04/2023
2Tyrosine Kinase InhibitorsIBA
10/2023 - 02/2015
2Adrenal Cortex Hormones (Corticosteroids)IBA
03/2022 - 10/2020
2B7-H1 AntigenIBA
10/2020 - 11/2016
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
10/2020 - 01/2020
2durvalumabIBA
10/2020 - 01/2018
2Epidermal Growth Factor (EGF)IBA
07/2020 - 01/2014
2Phenobarbital (Luminal)FDA Link
07/2020 - 01/2018
2Axitinib (AG 013736)IBA
01/2019 - 02/2015
2taxaneIBA
01/2019 - 10/2018
2enzalutamideIBA
10/2018 - 03/2015
2sipuleucel-T (APC8015)FDA Link
10/2018 - 01/2011
2Docetaxel (Taxotere)FDA Link
10/2018 - 10/2013
2LigandsIBA
02/2017 - 07/2014
2Dihydrotachysterol (AT 10)IBA
11/2016 - 01/2016
2pazopanibFDA Link
02/2015 - 10/2013
2Ethiodized Oil (Ethiodol)FDA Link
04/2014 - 03/2014
2TOR Serine-Threonine KinasesIBA
10/2013 - 12/2011
2tivozanibIBA
06/2012 - 12/2011
1Hematoxylin (Haematoxylon)IBA
12/2023
1Eosine Yellowish-(YS) (Eosin)IBA
12/2023
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
11/2023
1Oxidoreductases (Dehydrogenase)IBA
11/2023
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2023
1Lipase (Acid Lipase)FDA Link
01/2023
1Antineoplastic Agents (Antineoplastics)IBA
01/2023
1Drug CombinationsIBA
03/2022
1tocilizumab (atlizumab)FDA Link
03/2022
1C-Reactive ProteinIBA
03/2022

Therapy/Procedure

55Therapeutics
04/2024 - 01/2011
22Drug Therapy (Chemotherapy)
03/2024 - 01/2011
21Immunotherapy
04/2024 - 01/2011
11Castration
03/2024 - 05/2015
7Cystectomy
11/2023 - 07/2013
5Neoadjuvant Therapy
12/2023 - 02/2016
4Radiotherapy
11/2023 - 04/2014
4Artificial Respiration (Mechanical Ventilation)
10/2023 - 01/2023
3Aftercare (After-Treatment)
01/2020 - 11/2012
2Adjuvant Chemotherapy
11/2023 - 07/2022
2Image-Guided Radiotherapy
04/2014 - 03/2014
1Combination Drug Therapy (Combination Chemotherapy)
01/2023